• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Stepping on BioMarin's turf, PTC Therapeutics picks up PKU drug for a song

cafead

Administrator
Staff member
  • cafead   May 07, 2020 at 10:52: AM
via While industry-shaking M&A deals are still nowhere in sight, smaller deals by bargain shoppers continue to trickle in. PTC Therapeutics has joined the club, bagging Censa Pharmaceuticals and its rare metabolic disease drug.

article source